Shayna Sarosiek, Md

This study is testing whether combining the drug acalabrutinib with an antibody treatment (like rituximab) is safe and effective for people with nerve damage (neuropathy) caused by specific blood conditions. The goal is to control the underlying disease and improve or stabilize n…